Drug profile · INN
vidarabine
VIRA-A
vidarabine (VIRA-A) is a human herpesvirus 1 dna polymerase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — vidarabine
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
vidarabine (VIRA-A) is a human herpesvirus 1 dna polymerase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is vidarabine?
vidarabine (VIRA-A) is a human herpesvirus 1 dna polymerase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for vidarabine?
VIRA-A is a marketed brand name for vidarabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vidarabine?
vidarabine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.